N43CO110055-001 (N43) | |||
---|---|---|---|
Title | Melanoma-Targeted, Reversibly-Masked Nanoparticle for Systemic Delivery of Therap | ||
Institution | GRADALIS, INC., DALLAS, TX | ||
Principal Investigator | TEMPLETON, NANCY | NCI Program Director | N/A |
Cancer Activity | N/A | Division | N/A |
Funded Amount | $150,021 | Project Dates | 09/27/2011 - 06/27/2012 |
Fiscal Year | 2012 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) Gene Therapy (100.0%) |
Melanoma (100.0%) | ||
Research Type | |||
Systemic Therapies - Discovery and Development | |||
Abstract | |||
No abstract available. |